StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
SNTISenti Biosciences Holdings, Inc.
stockpulse.co.kr
Nasdaq
$0.1960▲ 4.03%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $6.1MShares out 31.1M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

36
  • 1d agoAfter-hours26.10.24 05:38
    4Ownership#●●●

    Senti Biosciences Holdings, Inc.

    Insider Rajangam Kanya of Senti Biosciences Holdings, Inc. reported changes in beneficial ownership of securities effective October 21, 2026. This filing is a Form 4 statement detailing the insider's updated equity holdings.…more

    $0.1960+4.03%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 1d agoAfter-hours26.10.24 05:37
    4Ownership

    Senti Biosciences Holdings, Inc.

    Insider Timothy K. Lu of Senti Biosciences reported a change in beneficial ownership of securities effective October 21, 2026. This filing formalizes the recent equity transaction by the executive.…more

    $0.1960+4.03%vs prev close
    View filingShare
  • 10.15After-hours26.10.16 05:02
    8-KKey event

    Senti Biosciences Holdings, Inc.

    Senti Biosciences received shareholder approval for its merger agreement with ST NewCo Limited at the annual meeting held on October 15, 2026. Shareholders also approved a reverse stock split at a ratio between 1-for-20 and 1-for-50, as well as the issuance of common stock exceeding 19.99% upon the exchange of Senior Secured Convertible Notes.…more

    $0.1960+4.03%vs prev close
    View filingShare

35 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 10.15After-hours26.10.16 05:06
    Bullish#●●●#●●●

    Senti Biosciences Approves Merger and Reverse Stock Split

    Senti Biosciences stockholders have approved the merger with ST NewCo and a reverse stock split ratio ranging from 1-for-20 to 1-for-50. This corporate action aims to restructure the company's capital base.…more

    $0.1960+4.03%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 9.24After-hours26.09.25 06:01

    ●●●●●●●● ●●●●● ●●●●●●

    Senti Biosciences has filed a prospectus for the resale of up to 25.55 million shares of common stock issuable upon the exchange of convertible notes. This registration facilitates the potential sale of shares by existing investors, which may lead to equity dilution.…more

    $0.1960+4.03%vs prev close
    ShareBenzinga

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →